Liraglutide 3.0 mg and mental health: can psychiatric symptoms be associated to adherence to therapy? Insights from a clinical audit

被引：0
作者：
Silvia Tempia Valenta
Michele Stecchi
Federica Perazza
Chiara Nuccitelli
Nicola Villanova
Loris Pironi
Anna Rita Atti
Maria Letizia Petroni
机构：
[1] Alma Mater University of Bologna,Department of Biomedical and NeuroMotor Sciences
[2] IRCCS-Azienda Ospedaliera di Bologna Sant’Orsola-Malpighi,Department of Medical and Surgical Sciences
[3] Alma Mater University of Bologna,undefined
来源：
Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity | / 28卷
关键词：
GLP-1 receptor agonists; Adherence; Depression; Anxiety; Binge eating; Obesity;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 252 条
  • [1] Haslam DW(2005)Obesity Lancet 366 1197-1209
  • [2] James WP(2016)Obesity statistics Prim Care 43 ix-135
  • [3] Smith KB(2017)Determinants of adherence to lifestyle intervention in adults with obesity: a systematic review Clin Obes 7 123-2890
  • [4] Smith MS(2013)Treatment outcomes and compliance according to obesity in patients with obstructive sleep apnea Eur Arch Otorhinolaryngol 270 2885-S52
  • [5] Burgess E(2017)Current pharmacotherapies for obesity: a practical perspective J Am Assoc Nurse Pract 29 S43-286
  • [6] Hassmén P(2021)The therapeutic potential of GLP-1 analogues for stress-related eating and role of GLP-1 in stress, emotion and mood: a review Prog Neuropsychopharmacol Biol Psychiatry 110 278-206
  • [7] Pumpa KL(2020)Comparative effectiveness of glucose-lowering drugs for type 2 diabetes: a systematic review and network meta-analysis Ann Intern Med 173 CD006423-147.e13
  • [8] Kim H(2011)Glucagon-like peptide analogues for type 2 diabetes mellitus Cochrane Database Syst Rev 5 194-576
  • [9] Kim MS(2007)Efficacy and safety of incretin therapy in type 2 diabetes: systematic review and meta-analysis JAMA 298 672-22
  • [10] Lee JE(2021)GLP-1 receptor agonists in the treatment of type 2 diabetes—state-of-the-art Mol Metab 46 137-649
12345678910